Corvus Pharmaceuticals Statistics Share Statistics Corvus Pharmaceuticals has 77.11M
shares outstanding. The number of shares has increased by 23.28%
in one year.
Shares Outstanding 77.11M Shares Change (YoY) 23.28% Shares Change (QoQ) 13.18% Owned by Institutions (%) 50.28% Shares Floating 54.56M Failed to Deliver (FTD) Shares 7,732 FTD / Avg. Volume 0.95%
Short Selling Information The latest short interest is 8.98M, so 11.65% of the outstanding
shares have been sold short.
Short Interest 8.98M Short % of Shares Out 11.65% Short % of Float 14.61% Short Ratio (days to cover) 15.86
Valuation Ratios The PE ratio is -5.24 and the forward
PE ratio is -6.58.
Corvus Pharmaceuticals's PEG ratio is
-0.06.
PE Ratio -5.24 Forward PE -6.58 PS Ratio 0 Forward PS 420.2 PB Ratio 10.02 P/FCF Ratio -12.83 PEG Ratio -0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Corvus Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.54,
with a Debt / Equity ratio of 0.03.
Current Ratio 1.54 Quick Ratio 1.54 Debt / Equity 0.03 Debt / EBITDA -0.04 Debt / FCF -0.04 Interest Coverage -15.1
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.01M Employee Count 31 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 18.75% in the
last 52 weeks. The beta is 0.41, so Corvus Pharmaceuticals's
price volatility has been higher than the market average.
Beta 0.41 52-Week Price Change 18.75% 50-Day Moving Average 4.17 200-Day Moving Average 5.1 Relative Strength Index (RSI) 51.48 Average Volume (20 Days) 816,612
Income Statement
Revenue n/a Gross Profit n/a Operating Income -27.55M Net Income -62.29M EBITDA -27.55M EBIT -60.47M Earnings Per Share (EPS) -1.02
Full Income Statement Balance Sheet The company has 8.74M in cash and 1.12M in
debt, giving a net cash position of 7.62M.
Cash & Cash Equivalents 8.74M Total Debt 1.12M Net Cash 7.62M Retained Earnings -397.01M Total Assets 59.44M Working Capital 36.21M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -25.42M
and capital expenditures 0, giving a free cash flow of -25.42M.
Operating Cash Flow -25.42M Capital Expenditures n/a Free Cash Flow -25.42M FCF Per Share -0.42
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
